#Intravenous Iron Drugs price

[creativeera]

The Iron Deficiency Anemia Treatment Market Is Thriving On Growing Demand

The iron deficiency anemia treatment market consists of oral iron replacement therapies that are used to treat low iron levels in the blood. Oral iron supplements offer convenience as they can be taken at home and have advantages like lower cost and fewer side effects compared to intravenous infusions. Iron deficiency anemia is a widespread nutritional disorder globally owing to insufficient dietary intake of iron or absorption issues. It can cause fatigue, weakness, and shortness of breath if left untreated. Global iron deficiency anemia treatment market is estimated to be valued at US$ 12.1 Bn in 2024 and is expected to reach US$ 21.6 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Key Takeaways Key players operating in the iron deficiency anemia treatment market are AdvaCare Pharma, Otsuka Pharmaceutical Co., Ltd., Sanofi, Emcure Pharmaceuticals, Wellona Pharma, SiNi Pharma Pvt Ltd, Sun Pharmaceutical Industries Ltd., Zydus Group, Akebia Therapeutics., Rockwell Medical, Inc., AbbVie Inc., Pfizer, Inc., Velnex Medicare, PHAEDRUS LIFE SCIENCE PVT. LTD., Inopha International Co, Limited, PharmaNutra S.p.A., Pharmascience Inc., American Regent, Inc. The growing Iron Deficiency Anemia Treatment Market Growth for oral iron replacement therapies owing to advantages like convenience of use and less side effects compared to intravenous infusions is fueling the market growth. Oral iron supplements can easily be taken at home without much supervision. The market is witnessing expansion in developing regions due to rising awareness and healthcare investments. There is a growing focus of market players on these regions through product launches, collaborations and mergers & acquisitions to strengthen their presence. Market Key Trends The market is witnessing high research and development activities by players to come up with innovative oral iron formulations. Iron Deficiency Anemia Treatment Market Size and Trends includes extended-release formulations with lower dosing frequency and tablets with enhanced biocompatibility for better iron absorption. Development of new pediatric formulations suitable for infants and children is also among the key research areas.

Porter’s Analysis Threat of new entrants: Low due to high costs involved to established production and distribution networks along with high capital requirements. Also, presence of few large players makes it difficult for new entrants. Bargaining power of buyers: Moderate as large number of generic alternatives available. However, severity and risk associated with condition increases buyer power. Bargaining power of suppliers: Moderate as raw material suppliers have limited control over pricing due to availability of substitutes. Threat of new substitutes: High due to emergence of alternative therapies and newer oral and injectable formulations. Competitive rivalry: Very high due to presence of many global and local players providing different treatment options. Intense competition keeps pricing pressure on existing products. Geographical Regions In terms of value, North America accounts for the largest share of the iron deficiency anemia treatment market due to growing prevalence of the disease and presence of advanced healthcare facilities. The U.S. is the major revenue generator within North America. Asia Pacific is the fastest growing region owing to rising geriatric population, increasing awareness regarding anemia, and improving access to healthcare services in emerging countries like India and China. The availability of low-cost generic drugs provides an impetus to market growth in Asia Pacific.

Get more insights on Iron Deficiency Anemia Treatment Market

Discover the Report for More Insights, Tailored to Your Language

French

German

Italian

Russian

Japanese

Chinese

Korean

Portuguese

Vaagisha brings over three years of expertise as a content editor in the market research domain. Originally a creative writer, she discovered her passion for editing, combining her flair for writing with a meticulous eye for detail. Her ability to craft and refine compelling content makes her an invaluable asset in delivering polished and engaging write-ups.

(LinkedIn: https://www.linkedin.com/in/vaagisha-singh-8080b91)

[markettrend24]

Updated Reports on Intravenous Iron Drugs Market Size, Growth, Revenue, Regional Analysis 2022-2028

Updated Reports on Intravenous Iron Drugs Market Size, Growth, Revenue, Regional Analysis 2022-2028

Global Intravenous Iron Drugs Market Report 2022- Detailed Analysis of the Market Structure Along with Key Players, Size, Share, Various Segments, Factors Affecting the Market Growth and Forecast 2028 The latest report, Intravenous Iron Drugs Market Size 2022, by manufacturer, region, types, and application, forecast till 2028 is analysed and researched on the basis of comprehensive analysis of…

[ramshariraut]

Intravenous Iron Drugs  Market 2021-2028 | By Regions: Europe, North America, China and Japan.

Global Intravenous Iron Drugs  Market, Geography (North America (United States, Canada and Mexico), South America (China, Japan, Korea, India and Southeast Asia), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), Middle East and Africa (Saudi Arabia, Egypt, Nigeria and South Africa)) Industry Trends 2021-2028

<strong>Market Overview</strong> Illustrative analysis of critical sides such as resulting factors and competitive landscape are conveyed with the help of significant resources, such as charts, tables, graphs. The report executes a deep investigation of drivers and restraints operating in the market. The report also evaluates the trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal according to different segments. The report also estimates the effect of different industrial sides on the Intravenous Iron Drugs   market divisions and regions. The research also divides the Intravenous Iron Drugs   Market on the basis of end-user, product type, application, and demography for the forecast period 2021–2028.

<strong> Request a sample Report of Intravenous Iron Drugs  Market @ <a href=https://www.statistifymarketresearch.com/reports/intravenous-iron-drugs-market/sample-request-84665>https://www.statistifymarketresearch.com/reports/intravenous-iron-drugs-market/sample-request-84665</a></strong>

<strong>Methodology</strong> The conditions influencing the market dynamics are considered and studied and examined to prepare an accurate report. In the report preparation process mainly two types of approaches are made- primary research approach and secondary research approach. In the primary research approach, both the supply and demand chain are interviewed where the supply chain consists of product, opinion leaders, etc. while the demand chain consists of industry experts. The secondary research approach involves various secondary sources like press releases, government agencies, and other commercial aspects of the market.

<strong>Report Summary</strong> Preparing a business report on Intravenous Iron Drugs    is the most important of all information-based writing because most of the business decisions are related to the organization after the evaluation of the situation as per the report. They are responsible for the documentation of the progress of the business and also serve several important purposes. The ability to write reports, quickly, and accurately is one of the key requirements of managers at every level. The reports allow them to convey vital information to subordinates and superiors. . The report on Intravenous Iron Drugs   prepared by us serves as a medium for understanding important business elements at the industrial and managerial level. Our report-making services entail flexible payment modes and budget-friendly rates.

<strong>Market segmentation</strong> The study splits the industry into a variety of sub-segments and thus represents the whole market. In addition, an estimate of the sales figures for the entire industry and its sub-segments are given in this report. It determines the variables that rapidly influence the market, including manufacturing methods and methodologies, channels for growth, and the product model. The report also outlines some of the biggest development opportunities, the introduction of the new products, market prediction, and forecasting, numerous economic factors that are key in deciding the Intravenous Iron Drugs  market pattern, buying decisions, and market attractiveness. The report would help stakeholders such as producers and distributors in finding and capturing high-potential markets. The research also addresses various environmental and regulatory critical factors.

<strong>Growth Mapping</strong> contains reason behind this report is to give a growth map with respect to the activities taken by key participants of the Intravenous Iron Drugs   market like item delivery, joint ventures,  influencing the Intravenous Iron Drugs   market and undertaking in general and furthermore influencing the business, import, fare, income and CAGR values. The report conveys the overall current realities about market definition, orders, applications, and commitment for the Intravenous Iron Drugs   market that are basic lead the market. The report moreover combines the overall organization profiles of the top players referred and also reflecting the drivers and limitations of the market with the support of SWOT analysis.

<strong>Top Listed Companies in the Intravenous Iron Drugs  Market Include</strong>

Allergan,Rockwell Medical,Galenica,AMAG Pharmaceuticals,NOXXON Pharma,Daiichi Sankyo,Wanbang Biopharmaceutical,Nippon Shinyaku,Pharmacosmos,Sanofi

<strong>Reasons to buy this report:</strong> Learn about the Covid-19 Impact on Intravenous Iron Drugs   market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements. To gain insightful analyses of the research Industry and have a comprehensive understanding of the global Intravenous Iron Drugs   market and its commercial landscape. To understand the future outlook and prospects for the Intravenous Iron Drugs   market with Marketing & Price (Price and Margin, Factors of Price Change, Manufacturers Gross Margin Analysis).

<strong>Request for Customization @ <a href=https://www.statistifymarketresearch.com/checkout/?currency=USD&type=single_user_license&report_id=84665>https://www.statistifymarketresearch.com/checkout/?currency=USD&type=single_user_license&report_id=84665</a></strong>

<strong>Regional Analysis</strong> Different regions of the world such as North America, Latin America, the Asia-Pacific region, Europe, and India, China, and Australia have been analyzed on the basis of various parameters that would benefit the development of the market in the area. It contains the territorial as well as the wide level investigation of the market. It was observed that North America and Asia-pacific countries have shown impressive development opportunities in their region. Asia-Pacific nations due to such a large population in the area could be the prime region for developing a fully flourishing market full of consumer and low-cost labor. However, Europe, being a region of most developed countries seems to be lagging in the survey due to its climatic-driven guidelines which will affect the new settlement of the market.

<strong>Customization of the report: </strong> The customized report is provided by our consultancy at a reasonable price. We provide updated information according to the requirements of the customers in the market world.

<strong>Benefits:</strong> 1. Well updated information. 2. Statistical report provided. 3. Discount offer in customization. 4. Service at the global level. 5. Company research report provided.

<strong>Services:</strong> 1. Expert analysts at your service. 2. Service according to your needs 3. Clearance of your queries. 4. Whole day service 5. Well updated Report.

<strong>Frequently Asked Questions?</strong> Q1. What is the total market value of the Intravenous Iron Drugs  market report? Q2. What would be the forecast period in the Intravenous Iron Drugs  market report? Q3. What is the base year considered in the Intravenous Iron Drugs   market report? Q4. Which are the top companies hold the market share in the Intravenous Iron Drugs   market ? Q5. Which is expected to be the fastest growing segment in the Intravenous Iron Drugs   market? Q6. Which market holds the maximum market share of the Intravenous Iron Drugs   market ? Q7. How the company profile has been selected? Q8. What will be the market value of the Intravenous Iron Drugs  market in 2028?

<strong>Why do companies trust Statistify Market Research?</strong> Statistify Market Research rendering surveys, indemnity, data, facts, enumeration on worldwide as well as local variables is one of the notable market research and expert company based in India. It covers automobiles, medicine, and healthcare, food and beverage, semiconductor and electronics market, chemicals, ICT(Information and Communications Technology), packaging, consumer goods. The flourishing company has a certain specified quality which provides customer satisfaction with excellent commitment and is highly time-oriented thus bringing positive results for our customers.

<strong>Company Name - Statistify Market Research</strong> Office Address - 156, Sector 9 Vasundhra Aptts Rohini, New Delhi 110085 IN Telephone Numbers - (+44) 162-237-1047 (+44) 162-237-1047 Email ID - <a href="mailto:sales@statistifymarketresearch.com"><strong>sales@statistifymarketresearch.com</strong></a> Contact Us – <a href="https://www.statistifymarketresearch.com/contact-us/"><strong>https://www.statistifymarketresearch.com/contact-us/</strong></a>

[statzyreportsmarketresearch]

(COVID-19 Version) Global Intravenous Iron Drugs Market

The report forecast global Intravenous Iron Drugs market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2025 due to coronavirus situation. The report offers detailed coverage of Intravenous Iron Drugs industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Intravenous Iron Drugs by geography. The report splits the market size, by volume and value, on the basis of application type and geography. First, this report covers the present status and the future prospects of the global Intravenous Iron Drugs market for 2015-2024. And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru]. At the same time, we classify Intravenous Iron Drugs according to the type, application by geography. More importantly, the report includes major countries market based on the type and application. Finally, the report provides detailed profile and data information analysis of leading Intravenous Iron Drugs company.

Key Content of Chapters as follows (Including and can be customized) : Part 1: Market Overview, Development, and Segment by Type, Application & Region Part 2: Company information, Sales, Cost, Margin etc. Part 3: Global Market by company, Type, Application & Geography Part 4: Asia-Pacific Market by Type, Application & Geography Part 5: Europe Market by Type, Application & Geography Part 6: North America Market by Type, Application & Geography Part 7: South America Market by Type, Application & Geography Part 8: Middle East & Africa Market by Type, Application & Geography Part 9: Market Features Part 10: Investment Opportunity Part 11: Conclusion

Market Segment as follows: By Region Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia] Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland] North America[United States, Canada, Mexico] Middle East & Africa[GCC, North Africa, South Africa] South America[Brazil, Argentina, Columbia, Chile, Peru] Key Companies Allergan AMAG Pharmaceuticals Daiichi Sankyo Galenica Pharmacosmos Nippon Shinyaku NOXXON Pharma Rockwell Medical Sanofi Wanbang Biopharmaceutical Market by Type Ferric Carboxy Maltose Sucrose Dextran Market by Application Hospital Drugstore Others

for sample report please visit:

Phone Number (IN) - +918484035727

(US) - +1415-871-0483

Email Address Email : info@statzyreports.com

Email : sales@statzyreports.com

for sample report please visit: https://www.statzyreports.com/report.php?reportnumber=SR151863&reportnames=COVID-19-Version-Global-Intravenous-Iron-Drugs-Market-Status-2015-2019-and-Forecast-2020-2025-by-Region-C-Product-Type--6-End-Use

Phone Number (IN) - +918484035727

(US) - +1415-871-0483

Email Address Email : info@statzyreports.com

Email : sales@statzyreports.com

[vitamininfusiontherapy]

‘I tried a vitamin IV drip for an energy boost – here’s what happened’

I'm pretty into discovering new methods to boost my power levels, which is why intravenous (IV) vitamin enhances piqued my interest. Sadly, needles are not my friend. I am the woman who passes out when she offers blood and also unconsciously closes down veins, which implies it's never ever as easy as "one little prick" for me. Naturally, this put me off.

I have actually had a vitamin B12 shot a few times as well as it was painful, so volunteering for an entire IV simply didn't seem worth it to me. Up until I chatted to a good friend, that had recently located a "trendy new IV Bar in Joburg" and vouched it did wonders for her skin. I'm guilty of chasing after the glow as much as the next lady, so I determined to take on up and go for it ...

Here's exactly what took place ...

Walking right into the IV Bar I didn't fairly know what to anticipate, yet much to my pleasure there were no hospital beds or frightening IV trolleys. Rather, I was greeted by friendly faces as well as wonderfully comfy elbow chairs. We discussed my demands and also determined that the "Energy Boost" IV was good for me-- with a high dosage of vitamins and also electrolytes as well as an added bonus offer of magnesium to help me sleep better.

The really gentle and also caring Registered nurse Paulina provided my IV and also after analyzing my arms determined it was good to pop the drip right into my hand. It was a little agonizing, however not what I would certainly developed it up to be (very frequently the situation). And after that I relaxed, relaxed and sucked on a couple of Shimmer sweets (these counter the metal preference you get from the drip), while the 15-minute vitamin increase entered my capillaries.

Energised ... But calmness

An extremely peaceful woman (slumped) in the chair alongside me, I later on found out, was having the "Headache Recovery" drip. She operates in bars as well as I presume hydration and also late nights are an occupational risk. It turns out she was a normal in the IV Bar, obviously looking for a means to balance her way of living. I watched her transform in front of me. As she completed her hydration therapy, she nearly bounced out of her chair and also spoke about the upcoming evening she needed to prep for.

When it comes to me, well my energy degrees quickly cheered up. I fulfilled a good friend for a piece of birthday cake after that and also really felt sharp and also thrilled to see her. I wasn't all buzzed the method you obtain from a high levels of caffeine overdose though; rather, I really felt a sense of peace.

We commemorated the very same good friend's birthday the adhering to night and also, needless to say, I awakened really feeling a little worse for wear. I couldn't aid however consider the lady from the IV Bar in the chair alongside me, as well as her hydration remedy. A week down the line, I truly have actually been sleeping good. Although, typical to the period I've picked up a little head cold. I recognize an "Health Increase" IV with 25 000mg of vitamin C is just what's needed to sort me out ... I think it's risk-free to claim I could be addicted.

Whatever you require to find out about vitamin IV trickles

While these IVs are a mix of vitamins and minerals that are currently discovered in your body, it's important to do your study as well as ensure whoever is administering your drip really is clued up. I sat down with Keri Krug, the proprietor of IV Bar, and also asked every little thing all of us would like to know about this most current wellness pattern ...

Before you visit and IV Bar, what qualifications etc. should you inspect the establishment for?

Safety is important! You want to make certain the intravenous vitamin centre is related to a doctor and a registered nurse is carrying out the drips. Despite the fact that it's vitamins and minerals and also is considered very secure, you wish to ensure the vitamins you are obtaining are worsened in a sterile center, and that the registered nurse has extensive experience in dripping customers. Additionally, from a logistical viewpoint, you wish to go somewhere that's welcoming, comfy and has a power. This is not an animosity purchase-- it's voluntarily, as well as you intend to enjoy your time there.

Do the IV leaks come with any type of adverse effects-- throughout, promptly after or the next day?

There are no adverse effects at all-- just may benefit! Very few people have reported a minor frustration after the detox drip, yet this is normal as the body is eliminating toxic substances ... however I've literally had one client report this. Some people get small bruising at the needle website, which once again is regular and also usually not excruciating. Many people, however, do not bruise as well as really feel the positive effects of the energy increase as well as health boost promptly.

What are the prices of the IV?

Our vitamin drips variety in between R650 and also R850, depending on the drip. We have actually selected to maintain our rates as low as feasible since we want our drips to be readily available to everybody-- not simply the stars as well as singers and also actors and also athletes who may manage a whole lot more. Our vitamin drips have the most productive and also safest substances at a budget-friendly cost.

How does the 'power increase' drip vary from a basic vitamin B shot?

The vitamin B shot typically just contains vitamin B12, while our energy boost has vitamin B complicated (thiamine, riboflavin, nicotinamide, pyridoxine, d-Panthenol), vitamin B12 as well as magnesium sulphate. The vitamin B12 complicated offers you the increase and helps reduce anxiety and stress and anxiety, while the magnesium helps with insomnia, pains, inflammation and migraine headaches.

We may give a much dose intravenously than would certainly be endured orally or through injectable, so you would certainly require four to 6 injections, one on an once a week basis, to have the exact same result as a 15-minute drip. Also, injectables have a 60% absorption price as several of the fluid enters into the muscular tissue, while an intravenous drip has a 100% absorption price, with the whole solution being provided straight into the blood stream. This additionally ensures results are promptly really felt.

Is there any person that shouldn't have an IV?

Practically every person may gain from vitamin IVs as they are vitamins and minerals and also thought about risk-free. Nevertheless, it is recommended that expecting women do not have drips because we don't recognize how much of the vitamins go across the placental barrier. Likewise, people with serious liver as well as kidney disorder may not have the ability to endure the drips either, but we will always check with their doctort and also get their permission if they would certainly like them to have a drip.

But those who do advantage abound! Besides the visual advantages of enhanced skin, and the natural regulation improvement for sporting activities lovers, in addition to the detoxification advantages, and the hydration treatment, those that profit mostly from vitamin IVs are the clinical situations:

Ladies with early ovarian ageing and also PCOS-- the glutathione enhances ovarian function as well as boosts the quality of eggs, so it's great for fertility treatment.

Individuals that experience frustrations and also migraines.

People that battle with anxiety, stress and also stress and anxiety.

Those with autoimmune problems such as rheumatoid arthritis, Crohn's condition as well as lupus.

Clients going through radiation treatment that are depleted of all nutrients.

Exists a clinical doctor present?

Indeed there is. Even though vitamin drips are considered risk-free, and our nurse is very knowledgeable, we like to have a medical professional on website. The majority of people have no unfavorable side effects, however a customer may not disclose drug they get on, or a condition they have, or they may not know of a hidden trouble or allergic reaction, as well as they might have a reaction. This would be the outright minority, however rather risk-free than sorry.

As a result of adding substances to an IV drip, there is a small risk of allergic reactions. While these risks are low, exactly how are you gotten ready to handle it in the event that one does happen?

The risk of an allergic reaction is very low. Medical drips, such as iron drips, posture a much larger threat that vitamin trickles, but of course it may occur, particularly if the customer has not revealed certain drug they are taking or an underlying condition they may have. In the not likely occasion of a reaction, a medical professional gets on website and our registered nurse is well trained. We have an anaphylactic kit available, as well as we have Hadley Shapiro as well as his group from MediResponse on rate dial.

The take home message-- a client should constantly fill out the client approval kind as truthfully as possible as well as reveal all details that could be appropriate to the dripping process. By doing this we may ensure they will certainly be safe and also gain all the positive may benefits of vitamin dripping.

The post “‘I tried a vitamin IV drip for an energy boost – here’s what happened’” was first appeared on health24

In Toronto? The IV Lounge is a full service IV vitamin therapy clinic offering intravenous infusions such as Hydration therapy, and high dose vitamin C just to mention a few.

[supermarkettrends]

Artery Stenosis Drug Market Will Accelerate Rapidly with Top Influencing Key players | Pfizer Inc, Eli Lilly and Company, Bristol-Myers Squibb Company.

Artery Stenosis Drug Market is a narrowing of the arteries that supply oxygen rich blood to vital organs and tissues such as brain, kidney and limbs. The causes of Artery stenosis is the deposition of plaque (atherosclerosis) inside the artery wall which reduces blood flow to the vital organs and tissues. Mostly people suffering from artery stenosis have no symptoms until the artery becomes severely narrowed. Symptoms generally occur with a mini-stroke followed by dizziness, fainting and blurred vision.

Artery stenosis drug market­ is expected to grow with the substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to rising patient awareness regarding early detection, prevention, and treatment of strokes.

 Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-artery-stenosis-drug-market

Competitive Analysis: Global Artery Stenosis Drug Market

Few of the major competitors currently working in Global Artery Stenosis Drug Market are Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, Eli Lilly and Company, Bristol-Myers Squibb Company, CELGENE CORPORATION, Takeda Pharmaceutical Company Limited, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Baxter, Medtronic, Johnson & Johnson Services, Inc, Cook Group among others.

 Key Pointers Covered in the Global Artery Stenosis Drug Market Trends and Forecast to 2026

Global   Artery Stenosis Drug Market New Sales Volumes

Global   Artery Stenosis Drug  Market Replacement Sales Volumes

Global   Artery Stenosis Drug Market Installed Base

Global   Artery Stenosis Drug Market By Brands

Global   Artery Stenosis Drug Market Size

Global   Artery Stenosis Drug  Market Procedure Volumes

Global   Artery Stenosis Drug Market Product Price Analysis

Global   Artery Stenosis Drug Market Healthcare Outcomes

Global   Artery Stenosis Drug Market Cost of Care Analysis

Global   Artery Stenosis Drug Market Regulatory Framework and Changes

Global   Artery Stenosis Drug Market Prices and Reimbursement Analysis

Global   Artery Stenosis Drug Market Shares in Different Regions

Recent Developments for Global   Artery Stenosis Drug Market Competitors

Global   Artery Stenosis Drug Market Upcoming Applications

Global   Artery Stenosis Drug Market Innovators Study

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=global-artery-stenosis-drug-market

Key Developments in the Market:

In February 2019, M.A. MedAlliance SA received Breakthrough Device designation from the U.S FDA for selution, sirolimus, sustained limus release (SLR) drug-eluting balloon (DEB) catheter, to treat coronary disease. This designation will provide company with the priority review and assistance from the FDA regarding device development and its approval.

In October 2018, Johnson & Johnson Services, Inc received the U.S FDA approval for Xarelto (rivaroxaban), factor Xa (FXa) inhibitor for the treatment of chronic coronary or peripheral artery disease. This drug is specifically approved for reducing the risk of major cardiovascular disorders such as stroke and myocardial infarction in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).

 Scope of the Artery Stenosis Drug Market

Global Artery Stenosis Drug Market By Indication Type (Carotid Artery Stenosis, Renal Artery Stenosis, Peripheral Artery Stenosis, Coronary Artery Stenosis and Others), Treatment (Medication and Surgery), Drugs (Atorvastatin, Fluvastatin, Heparin, Minoxidil, Aspirin and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2027

Artery stenosis drug market­ is expected to grow with the substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to rising patient awareness regarding early detection, prevention, and treatment of strokes.

Artery stenosis is a narrowing of the arteries that supply oxygen rich blood to vital organs and tissues such as brain, kidney and limbs. The causes of Artery stenosis is the deposition of plaque (atherosclerosis) inside the artery wall which reduces blood flow to the vital organs and tissues. Mostly people suffering from artery stenosis have no symptoms until the artery becomes severely narrowed. Symptoms generally occur with a mini-stroke followed by dizziness, fainting and blurred vision.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-artery-stenosis-drug-market

Key insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

Browse Related Report Here:

North America Nasal Spray Market

Chronic Iron Overload Market

[researchtrendingnews]

Artery Stenosis Drug Market Strategic Insights and key Business Influencing Factors | Major Players – Pfizer Inc, Eli Lilly and Company, Bristol-Myers Squibb Company.

Artery Stenosis Drug Market is a narrowing of the arteries that supply oxygen rich blood to vital organs and tissues such as brain, kidney and limbs. The causes of Artery stenosis is the deposition of plaque (atherosclerosis) inside the artery wall which reduces blood flow to the vital organs and tissues. Mostly people suffering from artery stenosis have no symptoms until the artery becomes severely narrowed. Symptoms generally occur with a mini-stroke followed by dizziness, fainting and blurred vision.

Artery stenosis drug market­ is expected to grow with the substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to rising patient awareness regarding early detection, prevention, and treatment of strokes.

 Get Sample Report at :

https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-artery-stenosis-drug-market

Competitive Analysis: Global Artery Stenosis Drug   Market

Few of the major competitors currently working in Global Artery Stenosis Drug Market are Abbott, GlaxoSmithKline plc, ALLERGAN, Novartis AG, Merck & Co., Inc, Sanofi, Pfizer Inc, Eli Lilly and Company, Bristol-Myers Squibb Company, CELGENE CORPORATION, Takeda Pharmaceutical Company Limited, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Baxter, Medtronic, Johnson & Johnson Services, Inc, Cook Group among others.

 Key Pointers Covered in the Global Artery Stenosis Drug Market Trends and Forecast to 2026

Global   Artery Stenosis Drug Market New Sales Volumes

Global   Artery Stenosis Drug  Market Replacement Sales Volumes

Global   Artery Stenosis Drug Market Installed Base

Global   Artery Stenosis Drug Market By Brands

Global   Artery Stenosis Drug Market Size

Global   Artery Stenosis Drug  Market Procedure Volumes

Global   Artery Stenosis Drug Market Product Price Analysis

Global   Artery Stenosis Drug Market Healthcare Outcomes

Global   Artery Stenosis Drug Market Cost of Care Analysis

Global   Artery Stenosis Drug Market Regulatory Framework and Changes

Global   Artery Stenosis Drug Market Prices and Reimbursement Analysis

Global   Artery Stenosis Drug Market Shares in Different Regions

Recent Developments for Global   Artery Stenosis Drug Market Competitors

Global   Artery Stenosis Drug Market Upcoming Applications

Global   Artery Stenosis Drug Market Innovators Study

Get Detailed TOC:

https://www.databridgemarketresearch.com/toc/?dbmr=global-artery-stenosis-drug-market

Key Developments in the Market:

In February 2019, M.A. MedAlliance SA received Breakthrough Device designation from the U.S FDA for selution, sirolimus, sustained limus release (SLR) drug-eluting balloon (DEB) catheter, to treat coronary disease. This designation will provide company with the priority review and assistance from the FDA regarding device development and its approval.

In October 2018, Johnson & Johnson Services, Inc received the U.S FDA approval for Xarelto (rivaroxaban), factor Xa (FXa) inhibitor for the treatment of chronic coronary or peripheral artery disease. This drug is specifically approved for reducing the risk of major cardiovascular disorders such as stroke and myocardial infarction in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).

 Scope of the Artery Stenosis Drug Market

Global Artery Stenosis Drug Market By Indication Type (Carotid Artery Stenosis, Renal Artery Stenosis, Peripheral Artery Stenosis, Coronary Artery Stenosis and Others), Treatment (Medication and Surgery), Drugs (Atorvastatin, Fluvastatin, Heparin, Minoxidil, Aspirin and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2027

Artery stenosis drug market­ is expected to grow with the substantial CAGR in the forecast period of 2020-2027. The report contains data of the base year 2019 and historic year 2018. This rise in market value can be attributed to rising patient awareness regarding early detection, prevention, and treatment of strokes.

Artery stenosis is a narrowing of the arteries that supply oxygen rich blood to vital organs and tissues such as brain, kidney and limbs. The causes of Artery stenosis is the deposition of plaque (atherosclerosis) inside the artery wall which reduces blood flow to the vital organs and tissues. Mostly people suffering from artery stenosis have no symptoms until the artery becomes severely narrowed. Symptoms generally occur with a mini-stroke followed by dizziness, fainting and blurred vision.

Speak to Author :

https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-artery-stenosis-drug-market

Key insights in the report:

Complete and distinct analysis of the market drivers and restraints

Key Market players involved in this industry

Detailed analysis of the Market Segmentation

Competitive analysis of the key players involved

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

Browse Related Report Here:

North America Nasal Spray Market

Chronic Iron Overload Market

[insurancepolicypro]

Readers And Tweeters Take Dialysis Suppliers To Activity: Nowhere However In The USA

Letters to the Editor is a periodic function. We welcome all feedback and can publish a variety. We edit for size and readability and require full names.

The Undue Pressure Of Dialysis

That is prison, and the dialysis firms aren’t the one ones plundering the general public (“Invoice Of The Month: First Kidney Failure, Then A $540,842 Invoice For Dialysis,” July 25). In case you have no medical insurance coverage and go to a physician or hospital for medical care, you get charged tenfold what they settle for from insurance coverage firms. No correctly run well being care facility or physician is shedding cash by accepting the agreed charges that the insurance coverage firms pay. It’s completely outrageous to cost individuals who can least afford to pay as much as 10 instances the insurance coverage costs. This rip-off has existed for many years and Congress has completed nothing to guard shoppers. My understanding is that no different nation permits this discrimination in opposition to the poor. It’s time this outrageous exploitation of shoppers be terminated.

— Jorg Meister, Middlegrove, N.Y.

Instruments like this are, sadly, essential to navigating the bewildering course of that’s making an attempt to acquire medical care.

— David W.S. Lieberman (@DwsLieberman) July 25, 2019

— David W.S. Lieberman, Somerville, Mass.

That is in response to the invoice of Sovereign and Jessica Valentine. It’s ridiculous that Fresenius can cost them $14,000 per session when dialysis in Mexico utilizing the identical dialysis machines and procedures runs $400 USD per session. I take my mom there regularly for trip, and we pay money for her dialysis periods.

—Martina Patella, Oakland, Calif.

That is simply insane. How can this occur in a so-called first world nation?

— Andrea Hilderman (@northarcagri) July 26, 2019

— Andrea Hilderman, Manitoba, Canada

I used to be appalled to learn your article on dialysis. I’ve an expensive good friend who constructed, opened and now operates a dialysis middle in Thessaloniki, Greece. His father is a kidney specialist of 30+ years. He wrote the string under about dialysis in Greece once I forwarded the story to him:

“In case you have insurance coverage dialysis is free Zero Free of charge The typical worth that dialysis services in Greece cost the Greek NHS is round 136 euros.

If a affected person who doesn’t have insurance coverage goes to a dialysis facility, he will probably be charged round 200 euros [about $223 in the United States]. That will probably be an amazing day for the ability.”

— Jerry Efremides, New York Metropolis

PBMs Put Sufferers In A Pickle

In addition to the delay of generic medicine to market (“California Invoice Would Combat Offers That Delay Generic Medicine,” Aug. 1), the pharmacy profit managers (PBMs) have offers with the producers, and pharmacies aren’t allowed to dispense a brand new generic as a result of the PBM won’t enable it to occur. Presently, there are Medicare plans that won’t pay for generic Ventolin or Advair and demand that we dispense the model title. It prices sufferers extra, the plan extra, and pharmacies lose by shelling out the brand-name medicine.

— David Smith, A & O Clinic Pharmacy, Salinas, Calif.

Profitable The Match Recreation

This isn’t information (“American Medical College students Much less Seemingly To Select To Grow to be Major Care Docs,” July three). Medical college students have been selecting the higher-end specialties over major care for many years. I’ve been within the well being care business for over 40 years and have labored with actually 1000’s of physicians as an govt at Cedars-Sinai Medical Middle and at my two firms, Observe Administration Data Corp. and Flash Code Options LLC. My daughter and her husband are each radiation oncologists. Board certification in the next specialty leads to increased revenue and higher profession selections. Why accept household follow in case you could be an orthopedic surgeon?

— James B. Davis, president and CEO of Observe Administration Data Corp., Beverly Hills, Calif.

I feel a discount within the quantity of doctor time devoted to administration duties (i.e. paperwork and EMR) must be rethought. Though folks have excessive pupil mortgage debt, as a physician we make greater than minimal wage so it shouldn’t be the largest deterrent.

— Jacqueline Ivey-Brown, MD (@JIveybrown) July 9, 2019

— Dr. Jacqueline Ivey-Brown, Chicago

Meds And Momentary Psychological Lapses

I learn your Navigating Growing older column about what number of drugs have an effect on older adults (“Widespread Medicines Can Masquerade As Dementia In Seniors,” July 18). I’m 85 and had two knee alternative surgical procedures. Each time I’ve to go to the dentist, I have to take 4 amoxicillin antibiotic tablets one hour earlier than the dentist appointment. I seen that after I took these antibiotics, my reminiscence grew to become very unhealthy. After a couple of days, I felt like myself once more.

— Janet Gileno, Bomoseen, Vt.

Widespread Medicines Can Masquerade As Dementia In Seniors https://t.co/6gAdUyMCmQ by way of @khnews – as a geriatrician, I have been preaching this to my sufferers for years. Once I speak to AARP teams and counsel that the “PM” medicine may not be secure, I get soiled seems. Unfold the phrase!

— James Richardson, MD, MPH (@DocRock54) July 18, 2019

— Dr. James P. Richardson, Baltimore

Weighing Prices And Advantages Of Intravenous Iron

I really feel your article about iron infusions (“Infusion Remedies — Wanted or Not — Can Deplete Sufferers’ Wallets” Aug. 2) was biased. The article didn’t focus on the explanations a doctor would possibly select to make use of IV iron to deal with a affected person versus oral iron – oral iron is just not nicely tolerated and within the presence of irritation within the physique is just not nicely absorbed. There are blood administration packages in america that commonly use IV iron to deal with anemia to lower the affected person’s threat for a blood transfusion. Though the price of IV iron differs from one drug to a different (the inexpensive medicine, akin to Ferrlecit, require a number of infusions), if you add up the associated fee, it consists of not solely the administration of the drug, however the nursing time and pharmacy preparation time for the medicine.

One additionally should think about the chance for response when selecting a selected type of IV iron. Anaphylactic reactions can happen in sufferers receiving IV iron. Injectafer is likely one of the medicine we use frequently as a result of different types of IV iron have a higher threat for response. One should think about the added value of treating an anaphylactic response in a affected person. Injectafer is a longer-acting type of IV iron; slow-release preparations akin to ferric carboxymaltose (Injectafer) are first taken up by macrophages, the shell is digested, and the iron is launched slowly over few days versus near-immediate iron launch present in different preparations that result in extra opposed reactions.

Though your story supplied the expertise of a single affected person, it didn’t report the “entire” story about why physicians use IV iron. I obtain no incentive for utilizing one drug over one other and should think about the affected person’s medical situation and the dangers related to giving IV iron. IV iron will appropriate iron ranges extra quickly in sufferers since you can provide the next focus of the drug, versus oral iron, which may take upward of a pair months to enhance iron ranges. With out actually figuring out the doctor’s rationale for utilizing IV iron within the case of the affected person within the article, the writer drew conclusions with out having all of the information. I agree that we actually want to have a look at well being care prices, however the writer of the article additionally failed to say Large Pharma’s position in driving up the price of well being care.

— David J. Sterken, Grand Rapids, Mich.

Medicare pays $1,600/vial for this. If neither Medicare nor non-public insurance coverage had been concerned to “negotiate” for the affected person, these would promote for lower than $100/vial. What a rip-off. Infusion Remedies — Wanted or Not — Can Deplete Sufferers’ Wallets https://t.co/wUob0POGwO

— Jim McMullen (@jimmcmullenkc1) August three, 2019

— Jim McMullen, Kansas Metropolis. Mo.

As a Board Licensed Oncology Pharmacist (BCOP), hematology/oncology is my subject. Our establishment used the cheaper iron (Venofer, which, at a low dose of 100 mg, must be given extra usually) for years. Medicare stopped paying for it as a result of the cost was lower than $100 — for some purpose, the federal insurance coverage program won’t hassle to pay for lower-cost IV medicine. Severely. We switched our formulary iron to Injectafer, 750 mg per vial (value to us ~$100-$750/vial, and the cost to sufferers per vial is about $1,000 and up), as a result of we had been reimbursed by Medicare for the Injectafer (as a result of it’s greater than $100).

You might be spot-on: The USA doesn’t give our wholesome iron-deficient sufferers sufficient time to profit from oral iron. We inject IV iron for iron-deficiency anemia even when the affected person doesn’t endure from something apart from unhealthy lab assessments.

Most hospitals and ambulatory care facilities base their formulary selections largely on reimbursement. Medicare can’t bid for drug pricing and doesn’t have a nationwide formulary. It is a critical error on the a part of the legislature and prices billions of or extra in taxpayer cash that goes instantly into the pocket of the pharmaceutical business. Not paying for lower-cost IV medicine is only one very small instance. It’s horrible for the sufferers who should bear the price of this discrepancy.

Reimbursement is a posh situation lately in no small half to the waste of the federal government.

— Mary Davis, Bellingham, Wash.

Infusion remedy is the tip of the iceberg for pricey therapies and surgical procedures with no profit to sufferers. #evidencebasedmedicine should be mandated to keep away from fraud, misinformation and deceptive sufferers

— Nicolas Argy, MD, JD (@NicolasArgy) August 2, 2019

— Dr. Nicolas Argy, Boston

Shefali Luthra’s article on intravenous iron is rife with error. The pricing is just not shut, relative prices are fallacious, and the implication of inappropriate use could also be appropriate solely primarily based on totally usurious costs listed.

Greater than 70% of these prescribed oral iron (PO) report important gastrointestinal (GI) perturbation, intolerance and non-adherence. PO iron causes diarrhea and constipation, gastric cramping, metallic style and thick, inexperienced tenacious stool. A yr of remedy is required to switch shops and proper hemoglobin concentrations, all of which could be completed with IV iron in 30 minutes. For folks with hereditary bleeding issues, there may be zero credible expectation oral iron can sustain with losses since 10% (most) of PO is absorbed and PO raises a protein, hepcidin, which blocks iron absorption for 24 to 48 hours, making sufficient repletion unrealistic.

InjectaFer is the most costly iron. It prices $843 for 750 milligrams. Primarily based on the preponderance of printed proof, a gram of iron in a single dose is about all we are able to make the most of. The beneficial dose of InjectaFer is 1,500 mg, $1,686 for a course (not vial) of iron. I feel that wastes 500 mg, and there may be double-blind, potential proof supporting that conclusion. It prices $100 for an workplace go to, chair time nursing and IVs, which takes 15 minutes. For those who go to twice, that’s a further $100.The fees you talked about counsel that an establishment in New York is fleecing its purchasers or insurance coverage firms. That is usury and must be investigated and stopped.

The well being economist Richard Pollock is mistaken. IV iron is extensively utilized in Nice Britain and this can be very probably, not unlikely, a affected person with power blood loss would get IV iron, regardless of signs. That being stated, Ferinject, the European title for InjectaFer, prices $140 per gram and well being suppliers don’t must cope with the ridiculous 750 mg vial we do. Feraheme prices $466 for 510 mg and requires two vials for a gram (1,020 mg). 4 insurers enable me to offer 1,020 mg in a single 30-minute infusion: the Blues, MedStar, Precedence Companions and Cigna. The remaining, together with Medicare and Medicaid, require two visits. The one profit is to our follow, which will get $100 for the fully pointless second go to. Regardless of making it clear the only 1,020 mg infusion is simply as secure and efficient, you halve the variety of IVs and possibilities for minor reactions. It’s not coated, I’ve no selection. A 3rd get it as soon as; two-thirds, twice. We cost $932 plus a 6% markup to cowl nursing prices and paraphernalia.

INFeD, or low molecular weight iron dextran, prices $243 per gram, comes as 100 mg vials and requires 10 vials for 1 gram. It takes an hour and is simply as secure and efficacious.

The writer is mistaken about Venofer, iron sucrose and Ferrlecit, ferric gluconate. You’ll be able to’t give greater than 200-250 mg as a result of the sugar that carries iron does a lot much less tightly than the carbohydrate cores of InjectaFer, Feraheme and INFeD. To provide a gram takes 4 to 5 visits. I by no means use these medicine for that purpose, however I’ve no criticism of nephrologists who use them in dialysis with thrice-weekly visits. Venofer is $600 per gram (positively greater than INFeD) and Ferrlecit $1,000 per gram.

The medical system you wrote is screwing the group. IV iron is an unmet want. Oral iron can’t sustain with losses in irregular uterine bleeding, be absorbed after bariatric surgical procedure, makes inflammatory bowel illness worse as a result of it’s instantly poisonous to the intestinal epithelium and makes the fallacious micro organism develop, and most of all doesn’t get to infants within the third trimester when the fetal mind wants iron for regular improvement. IV iron is a godsend for hundreds of thousands.

— Dr. Michael Auerbach, Baltimore

Right By Levels

The article “‘Local weather Grief’: Fears About The Planet’s Future Weigh On Individuals’ Psychological Well being” (July 18) stated a latest report by the Intergovernmental Panel on Local weather Change predicts that “by 2040 the Earth will heat by 2.7 levels Fahrenheit (1.5 levels Celsius).” Because the report’s opening web page (to which you hyperlink) says, by 2040 the Earth may have warmed by 2.7F above preindustrial ranges. That’s complete warming over 200 years, not future warming within the subsequent 22 years.

The report additionally offers little assist for the acute claims which have terrified so many individuals — and, even much less excusably, terrified so many kids. That is additionally true of many experiences by the foremost local weather businesses.

The IPCC is the most important and best-run venture of its variety, ever — an evaluation of present science, which is then summarized for non-scientists. The tragedy is that its work has been largely deserted for propaganda that exaggerates and even ignores the findings. I imagine this has prompted the gridlock in U.S. local weather coverage, in order that we’re not solely unprepared for future excessive climate, however for the inevitable repeat of previous excessive climate.

— Larry Kummer, editor of the Fabius Maximus web site, Davenport, Iowa

Editor’s observe: Heat thanks for stating the error. Our article has been up to date.

I imply, I would confer with extra as a crippling anxiousness than “grief” however as long as there’s a medical time period for it, positive: https://t.co/tphhE3J2R9

— Michelle Mills (@mlmills) July 18, 2019

— Michelle Mills, Chicago

For good purpose, we’re anxious about local weather change. Nevertheless it’s a slippery slope from saying we’re distressed, to declaring being concerned is a psychological well being dysfunction, to creating a pseudoscientific psychological dysfunction to proposing a remedy to cal not act. https://t.co/ySRVxxYaok

— James C.Coyne (@CoyneoftheRealm) July 21, 2019

— James C. Coyne, Philadelphia

Incrementally Exploited By Politicians

My copay requirement of $7,500 plus a month-to-month fee should be paid earlier than my insurance coverage pays any bills. This isn’t well being care. On paper I’ve well being care; however the actuality is I can’t afford to make use of it. It merely would cease me from chapter in case of an emergency. Nonetheless, these politicians and attorneys are making hundreds of thousands and getting quite a lot of publicity with each petition they file (“Biden’s ‘Incremental’ Well being Plan Nonetheless Would Be A Heavy Raise,” July 22).

I really feel the politicians ought to have the identical well being care selections because the American folks. This could assist them make higher selections. Democrats and Republicans know well being care within the U.S. is unaffordable. They need to all be fired for not doing their job.

I additionally imagine they need to be capable to serve solely two phrases, similar to the presidential workplace. Politicians deal with their place as a life-style as a substitute of a job.

— Catherine Mossner, Gladwin, Mich.

The Battle For Uniform Excellence In Tribal Care

I’m half Inupiaq Eskimo from northwestern Arctic Alaska. The article “How The Japanese Cherokee Took Management Of Their Well being Care”(July 22) states that the Cherokee benchmarked a program developed by Southcentral Basis, a Tribal Well being Group initially created by an ANCSA (Alaska Native Claims Settlement Act) company however allowed to function as a Public Regulation 93-638 entity. Awarded largely no-bid contracts via the Indian Well being Service, Southcentral Basis legally represents solely shareholders of Cook dinner Inlet Area Inc. — not all Alaska Native peoples.

To say SCF and different Alaska Natives run this system could also be partly correct, but it surely doesn’t give credit score to priceless contributors who served for many years guaranteeing we understood and applied packages designed for all cultures — even households associated to non-Indian Well being Service beneficiaries.

Augusta Reimer is a kind of deserving credit score for this program. She was the primary feminine Alaska Native/American Indian chief of an Indian Well being Service division and was largely accountable for creating an environment of wellness and creativity. Reimer, from IHS, and Mike McKeown from the College of Alaska-Anchorage designed my diploma in human companies; she spent hours working with interns and volunteers educating them on legal guidelines impacting us. Everybody who contributed deserves to be cited precisely and never simply in a aspect observe as different “Alaska Natives.”

The federal government has been fairly first rate about encouraging native peoples’ self-determination, but it surely doesn’t come with out duty to observe the requirements of care and communication and the legislation to make sure the standard and longevity of our packages.

The Indian Well being Service was not accredited to offer care to non-Indian well being service beneficiaries. So the Nuka system of care — initially referred to as Nutuqsiivik, which suggests “new beginnings” — was created to assist determine gaps in information that had been boundaries to offering care to households with a number of well being care suppliers and well being and socioeconomic points.

Indian Well being Service packages have come a good distance, however consistency and uniformity amongst tribal areas is very regarding. Within the age of a one-payer assessment, transparency is critically necessary. So is accuracy. Knowledge and the shortage thereof could cause a myriad of well being and financial points the affected person or buyer might must cope with whereas their tribal group isn’t monitored or corrected when wanted. With out competitors, I concern, these packages don’t adequately respect affected person wants, needs and don’t have any actual incentive to enhance the standard of their care to be able to preserve their clients.

The Alaska legislature has created a committee particularly designed to coach lawmakers and the general public on points affecting the general public and the tribes as a result of there are such a lot of of us. These packages don’t stay in a vacuum, however fairly influence native financial improvement and regulatory management over your group. I encourage accountability amongst all events and the mirroring of the U.S. Structure and legal guidelines, so we’ve a authorized template to observe.

— Cheryl Bowie, Anchorage, Alaska

from insurancepolicypro http://insurancepolicypro.com/?p=212

[azveille]

BIO: In conversation with Helen Torley, CEO of Halozyme

PHILADELPHIA—It has been a big year for Halozyme Therapeutics, and 2019’s not over yet. The biotech inked its ninth licensing deal for its drug delivery platform with its first biotech partner, saw promising data from its partnership with Johnson & Johnson and, later this year, will report its own data for an in-house program in pancreatic cancer.

The San Diego-based biotech operates under a two-pillar strategy—its Enhanze tech brings in licensing dollars and, eventually, milestones and royalties that bankroll its clinical programs. Enhanze uses the enzyme hyaluronidase to break down hyaluronan, a natural sugar chain that forms a gel in the innermost layer of skin. This allows drugs that would otherwise require hourslong intravenous infusion to be injected just under the skin.

It’s teamed up with the likes of Roche, AbbVie and Eli Lilly in addition to Johnson & Johnson and has seen three partnered products approved. The latest was a subcutaneous form of Roche’s breast cancer med Herceptin, which can be given to a patient in two to five minutes rather than an infusion that can take up to 90 minutes.

Phase 3 data for the subcutaneous version of J&J’s multiple myeloma drug Darzalex showed an even more dramatic change. The study, presented Monday at the annual meeting of the American Society for Clinical Oncology, showed that patients receiving subcutaneous Darzalex saw benefits at similar rates to patients on the infused drug—41% versus 37%. The Enhanze-based form of the blockbuster could cut treatment time from seven to eight hours for an infusion to just five minutes.

Halozyme’s lead program is a treatment for pancreatic cancer combining PEGPH20, a PEGylated version of the company’s hyaluronidase enzyme, with Celgene’s Abraxane and the chemo drug gemcitabine. Halozyme expects to report data for a phase 3 study later this year.

It has a second program in the pipeline targeting adenosine, but has put it on the back burner to throw its weight behind PEGPH20, CEO Helen Torley told FierceBiotech.

“The team discovered and started work on PEG-ADA2 three years ago, but we’ve paused the spend on that as we await the results of PEGPH20. Upon success, we’d want to add [PEG-ADA2] to the portfolio,” Torley said. “It’s still preclinical, so the spend to get it to the clinic would be better spent to get something already in the clinic forward to approval.”

When asked whether she thought Halozyme’s clinical work could be overshadowed by the Enhanze franchise, Torley said she didn’t worry about being pigeonholed as a platform provider.

“Our strategy is that, upon success of PEGPH20, we would add it to the portfolio and really become an oncology company. We will be adding interesting novel pathways and developing additional products there, so we’re not worried about getting niched at all,” she said.

Keeping the two businesses together makes the most sense for now. They work better together than they would alone—the company has “synergies” across both businesses, Torley said—and the arrangement makes Halozyme less reliant on the capital markets to fund its drug development programs. But that doesn't mean it won’t split the units up further down the line. If PEGPH20 doesn’t deliver, Halozyme will shift to an Enhanze-only model to stay afloat.

That said, Halozyme is preparing for success. It’s planning a U.S. launch of the pancreatic cancer treatment and is investigating a launch in Europe as well.

“Finalizing all of that will depend on the final decision on the profile of the drug… Meanwhile, we are doing all of the pre-launch activities—making sure we understand pricing and reimbursement … and how to state the value proposition to support the price,” Torley said.  

“We will be ready if we decide to do it,” she said.

Torley hasn’t been in a position to consider when to go public—Halozyme did so in 2004, 10 years before she took the helm. But, given the recent wave of biotech companies filing for IPOs at increasingly earlier stages—some with only preclinical data—she said, “it’s a mystery to me why people are going public.”

“A lot of the ones that went public early last year are well below their public price and that’s because it’s hard when a company is really early-stage to show the progress needed to support the price,” she said. "The ones I follow are all well underwater at this point in time, which will happen until their next clinical data.”

But, she conceded, it's a question of different perspectives and the economic environment.

“I would probably have been one of the ones that waited to have compelling clinical data. If you can find VC funding, there’s obviously plenty of funding available for companies,” she said.

“Some worry that the markets are closing. It is an open market at the moment, there is a willingness to invest. But they think about what might happen, for example, it could close soon.” Some biotechs are just looking to strike while the iron is hot.

[coolluminaryland-blog1]

Intravenous Iron Drugs Market to Witness Comprehensive Growth by 2025

Iron, one of the essential element, plays an important role in biological processes such as the synthesis of heme, energy metabolism, neurotransmitter production, formation of myoglobin, formation of collagen, and immune system function. Deficiency of iron is one of the major causes of iron deficiency anemia (IDA) associated with increased morbidity and mortality. According to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017, around 30% of anemia in women and children in developing countries is due to iron deficiency. In the 19th century, Pierre Blaud introduced ferrous sulfate which became the standard treatment for IDA.

Read Report Overview:  https://www.transparencymarketresearch.com/intravenous-iron-drugs-market.html

Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.

Major drivers of the IV iron drugs market are increase in incidence of iron deficiency, rise in chronic kidney disease patients undergoing dialysis, and surging diabetic population. Increase in iron deficiency anemia in gynecology, oncology, and gastroenterology, noncompliance of oral therapy, and accurate, easy, and convenient access to IV iron dosages drive demand for intravenous iron drugs. However, complex approval process, stringent regulations, drug side effects, nutraceutical alternatives to prevent iron deficiency, and product price are likely to act as major restraints of the IV iron drugs market.

The IV iron drugs market has been segmented based on product type and therapeutic area. Product types are ferric gluconate, ferric carboxyl maltose, iron sucrose, and iron dextran. Ferric gluconate accounts for the largest market share of the IV iron drugs market as it is one of the most effective forms of treatment of iron-deficiency anemia. However, at present, there is no data comparing it to existing preparations but it is expected to grow relatively faster due to the superior performance and increasing application.

Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25436

Based on therapeutic use, the IV iron drugs market has been divided into oncology, nephrology, gynecology, gastroenterology, heart failures, and surgeries. Increased usage of IV iron drugs among chronic kidney disease patients has led to the nephrology segment capturing the largest market share. Chronic Heart Failure is expected to be the fastest growing segment owing to rise in number of patients with heart related disorders.

In terms of region, the intravenous iron drugs market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America accounts for the major market share owing to rise in use of intravenous iron drugs in oncology. The market in emerging countries such as India and China in Asia Pacific is expected witness strong growth due to increasing investment by governments and private companies in biotechnology and biopharmaceutical industry, growing investment opportunities in developing countries, increase in diagnostic laboratories, and rise in prevalence of IDA among women in the developing countries. The intravenous iron drugs market is competitive, owing to emergence of new entrants in the market and presence of well-established firms.

Request For TOC : https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=25436

Key players in the intravenous iron drugs market are Allergan, Inc., AMAG Pharmaceuticals. Inc., Galenica Ltd., Actavis, Inc., American Regent. Inc., Sanofi, Luitpold Pharmaceuticals, Inc., Fresenius Medical Care AG & Co., Pharmacosmos A/S, and Vifor Pharma Ltd.

About us:

Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:

Transparency Market Research 90 State Street, Suite 700, Albany NY – 12207 United States Tel: +1-518-618-1030 USA – Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/

[morrisbeck07-blog]

Intravenous (IV) Iron Drugs Market 2019

Intravenous (IV) Iron Drugs Market 2019

Global Intravenous (IV) Iron Drugs Masks Market Report 2019 – Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the Global Intravenous (IV) Iron Drugs Masks Industry. The global Intravenous (IV) Iron Drugs Masks market size of is xxx million in 2018 with XX CAGR from 2015 to 2018, and it is expected to reach xxx million by the end of 2024…

[pragya1-blog]

Intravenous Iron Drugs Market: Shares, Strategies and Forecasts, Analysis and Overview upto 2025

Iron, one of the essential element, plays an important role in biological processes such as the synthesis of heme, energy metabolism, neurotransmitter production, formation of myoglobin, formation of collagen, and immune system function. Deficiency of iron is one of the major causes of iron deficiency anemia (IDA) associated with increased morbidity and mortality. According to a survey conducted by the Vitamin and Mineral Nutrition Information System in 2017, around 30% of anemia in women and children in developing countries is due to iron deficiency. In the 19th century, Pierre Blaud introduced ferrous sulfate which became the standard treatment for IDA.

Iron supplements are available in two forms: oral and intravenous. Intravenous iron preparations are superior to oral supplements, as these lead to higher and faster increase in iron and Hb levels. Oral supplements have disadvantages such as GI adverse events, poor adherence, poor gastrointestinal absorption, and non-compliance.

Obtain Report Details @

https://www.transparencymarketresearch.com/intravenous-iron-drugs-market.html

Major drivers of the IV iron drugs market are increase in incidence of iron deficiency, rise in chronic kidney disease patients undergoing dialysis, and surging diabetic population. Increase in iron deficiency anemia in gynecology, oncology, and gastroenterology, noncompliance of oral therapy, and accurate, easy, and convenient access to IV iron dosages drive demand for intravenous iron drugs. However, complex approval process, stringent regulations, drug side effects, nutraceutical alternatives to prevent iron deficiency, and product price are likely to act as major restraints of the IV iron drugs market.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25436

The IV iron drugs market has been segmented based on product type and therapeutic area. Product types are ferric gluconate, ferric carboxyl maltose, iron sucrose, and iron dextran. Ferric gluconate accounts for the largest market share of the IV iron drugs market as it is one of the most effective forms of treatment of iron-deficiency anemia. However, at present, there is no data comparing it to existing preparations but it is expected to grow relatively faster due to the superior performance and increasing application. Based on therapeutic use, the IV iron drugs market has been divided into oncology, nephrology, gynecology, gastroenterology, heart failures, and surgeries. Increased usage of IV iron drugs among chronic kidney disease patients has led to the nephrology segment capturing the largest market share. Chronic Heart Failure is expected to be the fastest growing segment owing to rise in number of patients with heart related disorders.

Enquiry for Discount on this Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=25436

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research State Tower, 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: www.transparencymarketresearch.com

[big--news]

You’ve helped us fight HIV. Now, let’s end it. This World AIDS Day join the fight to end the negative impact of HIV

Times have changed. People don’t wait to be married to have sex. The fact that it is a natural desire that comes with puberty and hormones play a major role in initiating this desire is slowing gaining acceptability. According to Dr. Dhrity Vats, Senior Wellness Consultant, Healthians (www.healthians.com), “Even in today’s era, the word SEX is considered to be a taboo; any open discussion is shunned and people till date prefer to talk in whispers. This fuels the misconceptions about sexual interactions and related complications, if any. But, with thegrowing number of sexual interactions between individuals, safety and awareness should be the top most priority. Rather, safety comes with awareness.” So, if last night you had unprotected sex with a partner whose HIV status is not known, both of you should get tested.

Had unprotected sex? Don’t shy from an HIV test

It is best to have protected sex, but if you were not protected then chances of getting a sexually transmitted disease is very high, especially if your sexual partner is exposed to HIV.

What is unprotected Sex & how is HIV passed during unprotected sex?

Involvement in any sexual activity where a condom is not used is known as unprotected sex. A condom can be used by both or any one partner. A sexual contact with someone who has HIV greatly increases your chances of contracting the virus. Moreover, in the absence of condom, the body fluids come in contact with each other such as the blood, semen, vaginal fluids, pre-cum or anal mucus and the virus transmits to the blood stream of the sexual partner.

It is a myth that STD including HIV/AIDS can only be transmitted through vaginal sex. According to research, it is most commonly spread my anal sex as the lining of the anus is thinner and is torn easily. When the HIV-infected semen comes in contact with the broken skin chances of getting infected are high. Same is in the case of oral sex. If you have ulcers or broken skin, that too can be risky.

HIV is passed via the delicate and absorbent mucous skin of:

the penis,

vagina,

lining of the rectum,

the mouth and throat (if broken skin area)

What are the methods of protected sex

For protection against HIV/AIDS, it is important to understand that it is the body fluids which should not come in contact. For this, no contraceptive pill or intrauterine device would help. Theonly and preferred way of protection is a condom. Now-a-days condoms are available for both men and women. A condom gives a complete lining of latex and does not let the semen come in contact with the broken skin.

Who is at risk?

Anybody can be affected by the HIV. The way you get HIV can vary. HIV positive people do not generally come to know how they got the virus but its carrier is bloodstream or body fluids. You can be at a risk of having HIV if

you have multiple sex partners

you had sex—anal or vaginal—with an HIV-positive partner

you have been diagnosed with or treated for Hepatitis or Tuberculosis (TB)

your partner or you have any sexually transmitted infection.

you take drugs through injections.

How to get tested?

If you had unprotected sex and are worried that your partner might be HIV positive, get yourself tested. You would be counselled and given a questionnaire by the doctor before you are advised for this test. The test is a simple blood test. The phlebotomist shall take a sterile sample of your blood and study it in the laboratory for HIV antibodies. Sometimes, the HIV may be negative in spite of you being exposed to the virus. This is because the virus has an incubation period of 3 to 12 weeks (21-84 days) called the ‘window period’. In most cases, an individual shows symptoms of being infected by this virus within 6-12 months.

How can HIV be prevented?

The risk of getting the HIV can be lowered by

limiting the number of sexual partners

knowing if your partner is HIV positive

using a condom regularly for all kinds of sex

getting screened for other sexually transmitted infections

avoiding using intravenous drugs

not sharing needles

If you had unprotected sex with someone whose HIV status is not known to you, get yourself tested soon to a avoid complications and to begin quick treatment. Since there is no age bar as to when you can or should have sex, similarly there is no age bar for getting HIV. In a homosexual relationship too, you have to be careful not to get any sexually transmitted disease. Prevention is always better than cure, especially in the case when there is no cure. But, if no precautions were used, a timely test is the only option to avoid further complications.

Healthians.com is India’s largest health test @ home service, creating a new benchmark for very high quality and honest prices. Healthians employs state of art 46 touchpoints technology for assuring quality collection and testing across its tightly controlled network of labs and hundreds of full-time phlebotomists. Coolsure ™ and Blackcode technology ensure sample transportation in an environment proof way- safe from heat, sunlight, contamination and human error. Smartprick ™ technology ensures minimum pain by precision laser guided blood collection. It specialises in Diagnostic, Preventive and Chronic Disease Management. We guarantee you the most accurate results for tests like complete hemogram (CBC), blood sugar, liver function test (LFT), kidney function test (KFT), lipid profile, Dengue (NS1 and antigen), Chikungunya (PCR and IgM antibody), Typhoid, HbA1c, Glucose, Iron Serum, Thyroid, Pancreatic profile, Electrolytes profile, Vitamins profile and full body checkup. To know more please log-on to www.healthians.com or to download the app ( https://play.google.com/store/apps/details?id=com.healthians.main.healthians&hl=en)

[sangli-varta]

You’ve helped us fight HIV. Now, let’s end it. This World AIDS Day join the fight to end the negative impact of HIV

Times have changed. People don’t wait to be married to have sex. The fact that it is a natural desire that comes with puberty and hormones play a major role in initiating this desire is slowing gaining acceptability. According to Dr. Dhrity Vats, Senior Wellness Consultant, Healthians (www.healthians.com), “Even in today’s era, the word SEX is considered to be a taboo; any open discussion is shunned and people till date prefer to talk in whispers. This fuels the misconceptions about sexual interactions and related complications, if any. But, with thegrowing number of sexual interactions between individuals, safety and awareness should be the top most priority. Rather, safety comes with awareness.” So, if last night you had unprotected sex with a partner whose HIV status is not known, both of you should get tested.

Had unprotected sex? Don’t shy from an HIV test

It is best to have protected sex, but if you were not protected then chances of getting a sexually transmitted disease is very high, especially if your sexual partner is exposed to HIV.

What is unprotected Sex & how is HIV passed during unprotected sex?

Involvement in any sexual activity where a condom is not used is known as unprotected sex. A condom can be used by both or any one partner. A sexual contact with someone who has HIV greatly increases your chances of contracting the virus. Moreover, in the absence of condom, the body fluids come in contact with each other such as the blood, semen, vaginal fluids, pre-cum or anal mucus and the virus transmits to the blood stream of the sexual partner.

It is a myth that STD including HIV/AIDS can only be transmitted through vaginal sex. According to research, it is most commonly spread my anal sex as the lining of the anus is thinner and is torn easily. When the HIV-infected semen comes in contact with the broken skin chances of getting infected are high. Same is in the case of oral sex. If you have ulcers or broken skin, that too can be risky.

HIV is passed via the delicate and absorbent mucous skin of:

the penis,

vagina,

lining of the rectum,

the mouth and throat (if broken skin area)

What are the methods of protected sex

For protection against HIV/AIDS, it is important to understand that it is the body fluids which should not come in contact. For this, no contraceptive pill or intrauterine device would help. Theonly and preferred way of protection is a condom. Now-a-days condoms are available for both men and women. A condom gives a complete lining of latex and does not let the semen come in contact with the broken skin.

Who is at risk?

Anybody can be affected by the HIV. The way you get HIV can vary. HIV positive people do not generally come to know how they got the virus but its carrier is bloodstream or body fluids. You can be at a risk of having HIV if

you have multiple sex partners

you had sex—anal or vaginal—with an HIV-positive partner

you have been diagnosed with or treated for Hepatitis or Tuberculosis (TB)

your partner or you have any sexually transmitted infection.

you take drugs through injections.

How to get tested?

If you had unprotected sex and are worried that your partner might be HIV positive, get yourself tested. You would be counselled and given a questionnaire by the doctor before you are advised for this test. The test is a simple blood test. The phlebotomist shall take a sterile sample of your blood and study it in the laboratory for HIV antibodies. Sometimes, the HIV may be negative in spite of you being exposed to the virus. This is because the virus has an incubation period of 3 to 12 weeks (21-84 days) called the ‘window period’. In most cases, an individual shows symptoms of being infected by this virus within 6-12 months.

How can HIV be prevented?

The risk of getting the HIV can be lowered by

limiting the number of sexual partners

knowing if your partner is HIV positive

using a condom regularly for all kinds of sex

getting screened for other sexually transmitted infections

avoiding using intravenous drugs

not sharing needles

If you had unprotected sex with someone whose HIV status is not known to you, get yourself tested soon to a avoid complications and to begin quick treatment. Since there is no age bar as to when you can or should have sex, similarly there is no age bar for getting HIV. In a homosexual relationship too, you have to be careful not to get any sexually transmitted disease. Prevention is always better than cure, especially in the case when there is no cure. But, if no precautions were used, a timely test is the only option to avoid further complications.

Healthians.com is India’s largest health test @ home service, creating a new benchmark for very high quality and honest prices. Healthians employs state of art 46 touchpoints technology for assuring quality collection and testing across its tightly controlled network of labs and hundreds of full-time phlebotomists. Coolsure ™ and Blackcode technology ensure sample transportation in an environment proof way- safe from heat, sunlight, contamination and human error. Smartprick ™ technology ensures minimum pain by precision laser guided blood collection. It specialises in Diagnostic, Preventive and Chronic Disease Management. We guarantee you the most accurate results for tests like complete hemogram (CBC), blood sugar, liver function test (LFT), kidney function test (KFT), lipid profile, Dengue (NS1 and antigen), Chikungunya (PCR and IgM antibody), Typhoid, HbA1c, Glucose, Iron Serum, Thyroid, Pancreatic profile, Electrolytes profile, Vitamins profile and full body checkup. To know more please log-on to www.healthians.com or to download the app ( https://play.google.com/store/apps/details?id=com.healthians.main.healthians&hl=en)

[flash--news]

You’ve helped us fight HIV. Now, let’s end it. This World AIDS Day join the fight to end the negative impact of HIV

Times have changed. People don’t wait to be married to have sex. The fact that it is a natural desire that comes with puberty and hormones play a major role in initiating this desire is slowing gaining acceptability. According to Dr. Dhrity Vats, Senior Wellness Consultant, Healthians (www.healthians.com), “Even in today’s era, the word SEX is considered to be a taboo; any open discussion is shunned and people till date prefer to talk in whispers. This fuels the misconceptions about sexual interactions and related complications, if any. But, with thegrowing number of sexual interactions between individuals, safety and awareness should be the top most priority. Rather, safety comes with awareness.” So, if last night you had unprotected sex with a partner whose HIV status is not known, both of you should get tested.

Had unprotected sex? Don’t shy from an HIV test

It is best to have protected sex, but if you were not protected then chances of getting a sexually transmitted disease is very high, especially if your sexual partner is exposed to HIV.

What is unprotected Sex & how is HIV passed during unprotected sex?

Involvement in any sexual activity where a condom is not used is known as unprotected sex. A condom can be used by both or any one partner. A sexual contact with someone who has HIV greatly increases your chances of contracting the virus. Moreover, in the absence of condom, the body fluids come in contact with each other such as the blood, semen, vaginal fluids, pre-cum or anal mucus and the virus transmits to the blood stream of the sexual partner.

It is a myth that STD including HIV/AIDS can only be transmitted through vaginal sex. According to research, it is most commonly spread my anal sex as the lining of the anus is thinner and is torn easily. When the HIV-infected semen comes in contact with the broken skin chances of getting infected are high. Same is in the case of oral sex. If you have ulcers or broken skin, that too can be risky.

HIV is passed via the delicate and absorbent mucous skin of:

the penis,

vagina,

lining of the rectum,

the mouth and throat (if broken skin area)

What are the methods of protected sex

For protection against HIV/AIDS, it is important to understand that it is the body fluids which should not come in contact. For this, no contraceptive pill or intrauterine device would help. Theonly and preferred way of protection is a condom. Now-a-days condoms are available for both men and women. A condom gives a complete lining of latex and does not let the semen come in contact with the broken skin.

Who is at risk?

Anybody can be affected by the HIV. The way you get HIV can vary. HIV positive people do not generally come to know how they got the virus but its carrier is bloodstream or body fluids. You can be at a risk of having HIV if

you have multiple sex partners

you had sex—anal or vaginal—with an HIV-positive partner

you have been diagnosed with or treated for Hepatitis or Tuberculosis (TB)

your partner or you have any sexually transmitted infection.

you take drugs through injections.

How to get tested?

If you had unprotected sex and are worried that your partner might be HIV positive, get yourself tested. You would be counselled and given a questionnaire by the doctor before you are advised for this test. The test is a simple blood test. The phlebotomist shall take a sterile sample of your blood and study it in the laboratory for HIV antibodies. Sometimes, the HIV may be negative in spite of you being exposed to the virus. This is because the virus has an incubation period of 3 to 12 weeks (21-84 days) called the ‘window period’. In most cases, an individual shows symptoms of being infected by this virus within 6-12 months.

How can HIV be prevented?

The risk of getting the HIV can be lowered by

limiting the number of sexual partners

knowing if your partner is HIV positive

using a condom regularly for all kinds of sex

getting screened for other sexually transmitted infections

avoiding using intravenous drugs

not sharing needles

If you had unprotected sex with someone whose HIV status is not known to you, get yourself tested soon to a avoid complications and to begin quick treatment. Since there is no age bar as to when you can or should have sex, similarly there is no age bar for getting HIV. In a homosexual relationship too, you have to be careful not to get any sexually transmitted disease. Prevention is always better than cure, especially in the case when there is no cure. But, if no precautions were used, a timely test is the only option to avoid further complications.

Healthians.com is India’s largest health test @ home service, creating a new benchmark for very high quality and honest prices. Healthians employs state of art 46 touchpoints technology for assuring quality collection and testing across its tightly controlled network of labs and hundreds of full-time phlebotomists. Coolsure ™ and Blackcode technology ensure sample transportation in an environment proof way- safe from heat, sunlight, contamination and human error. Smartprick ™ technology ensures minimum pain by precision laser guided blood collection. It specialises in Diagnostic, Preventive and Chronic Disease Management. We guarantee you the most accurate results for tests like complete hemogram (CBC), blood sugar, liver function test (LFT), kidney function test (KFT), lipid profile, Dengue (NS1 and antigen), Chikungunya (PCR and IgM antibody), Typhoid, HbA1c, Glucose, Iron Serum, Thyroid, Pancreatic profile, Electrolytes profile, Vitamins profile and full body checkup. To know more please log-on to www.healthians.com or to download the app ( https://play.google.com/store/apps/details?id=com.healthians.main.healthians&hl=en)

[varansai-varta]

You’ve helped us fight HIV. Now, let’s end it. This World AIDS Day join the fight to end the negative impact of HIV

Times have changed. People don’t wait to be married to have sex. The fact that it is a natural desire that comes with puberty and hormones play a major role in initiating this desire is slowing gaining acceptability. According to Dr. Dhrity Vats, Senior Wellness Consultant, Healthians (www.healthians.com), “Even in today’s era, the word SEX is considered to be a taboo; any open discussion is shunned and people till date prefer to talk in whispers. This fuels the misconceptions about sexual interactions and related complications, if any. But, with thegrowing number of sexual interactions between individuals, safety and awareness should be the top most priority. Rather, safety comes with awareness.” So, if last night you had unprotected sex with a partner whose HIV status is not known, both of you should get tested.

Had unprotected sex? Don’t shy from an HIV test

It is best to have protected sex, but if you were not protected then chances of getting a sexually transmitted disease is very high, especially if your sexual partner is exposed to HIV.

What is unprotected Sex & how is HIV passed during unprotected sex?

Involvement in any sexual activity where a condom is not used is known as unprotected sex. A condom can be used by both or any one partner. A sexual contact with someone who has HIV greatly increases your chances of contracting the virus. Moreover, in the absence of condom, the body fluids come in contact with each other such as the blood, semen, vaginal fluids, pre-cum or anal mucus and the virus transmits to the blood stream of the sexual partner.

It is a myth that STD including HIV/AIDS can only be transmitted through vaginal sex. According to research, it is most commonly spread my anal sex as the lining of the anus is thinner and is torn easily. When the HIV-infected semen comes in contact with the broken skin chances of getting infected are high. Same is in the case of oral sex. If you have ulcers or broken skin, that too can be risky.

HIV is passed via the delicate and absorbent mucous skin of:

the penis,

vagina,

lining of the rectum,

the mouth and throat (if broken skin area)

What are the methods of protected sex

For protection against HIV/AIDS, it is important to understand that it is the body fluids which should not come in contact. For this, no contraceptive pill or intrauterine device would help. Theonly and preferred way of protection is a condom. Now-a-days condoms are available for both men and women. A condom gives a complete lining of latex and does not let the semen come in contact with the broken skin.

Who is at risk?

Anybody can be affected by the HIV. The way you get HIV can vary. HIV positive people do not generally come to know how they got the virus but its carrier is bloodstream or body fluids. You can be at a risk of having HIV if

you have multiple sex partners

you had sex—anal or vaginal—with an HIV-positive partner

you have been diagnosed with or treated for Hepatitis or Tuberculosis (TB)

your partner or you have any sexually transmitted infection.

you take drugs through injections.

How to get tested?

If you had unprotected sex and are worried that your partner might be HIV positive, get yourself tested. You would be counselled and given a questionnaire by the doctor before you are advised for this test. The test is a simple blood test. The phlebotomist shall take a sterile sample of your blood and study it in the laboratory for HIV antibodies. Sometimes, the HIV may be negative in spite of you being exposed to the virus. This is because the virus has an incubation period of 3 to 12 weeks (21-84 days) called the ‘window period’. In most cases, an individual shows symptoms of being infected by this virus within 6-12 months.

How can HIV be prevented?

The risk of getting the HIV can be lowered by

limiting the number of sexual partners

knowing if your partner is HIV positive

using a condom regularly for all kinds of sex

getting screened for other sexually transmitted infections

avoiding using intravenous drugs

not sharing needles

If you had unprotected sex with someone whose HIV status is not known to you, get yourself tested soon to a avoid complications and to begin quick treatment. Since there is no age bar as to when you can or should have sex, similarly there is no age bar for getting HIV. In a homosexual relationship too, you have to be careful not to get any sexually transmitted disease. Prevention is always better than cure, especially in the case when there is no cure. But, if no precautions were used, a timely test is the only option to avoid further complications.

Healthians.com is India’s largest health test @ home service, creating a new benchmark for very high quality and honest prices. Healthians employs state of art 46 touchpoints technology for assuring quality collection and testing across its tightly controlled network of labs and hundreds of full-time phlebotomists. Coolsure ™ and Blackcode technology ensure sample transportation in an environment proof way- safe from heat, sunlight, contamination and human error. Smartprick ™ technology ensures minimum pain by precision laser guided blood collection. It specialises in Diagnostic, Preventive and Chronic Disease Management. We guarantee you the most accurate results for tests like complete hemogram (CBC), blood sugar, liver function test (LFT), kidney function test (KFT), lipid profile, Dengue (NS1 and antigen), Chikungunya (PCR and IgM antibody), Typhoid, HbA1c, Glucose, Iron Serum, Thyroid, Pancreatic profile, Electrolytes profile, Vitamins profile and full body checkup. To know more please log-on to www.healthians.com or to download the app ( https://play.google.com/store/apps/details?id=com.healthians.main.healthians&hl=en)